We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

Unilever Seeks Divorce over Hoodia

November 14, 2008: 07:27 PM EST
Unilever is discussing terminating a development agreement with Phytopharm to create a drink-based format using hoodia extract. The company is not satisfied with the results of clinical studies. The two companies signed a license and joint development agreement in December 2004. Unilever says the product is not suitable for its portfolio, while Phytopharm believes that pre-clinical and clinical data justify further work in the areas of obesity, and pharmaceutical and veterinary applications. Hoodia extract has been shown to reduce caloric intake in overweight subjects. Phytopharm says it will seek other partners.
"Phytopharm in Talks with Unilever to End Hoodia Extract Pact,", November 14, 2008, © CNS Media
Diet Insights
Market News
United Kingdom
Companies, Organizations
Deals, M&A, JVs, Licensing
Market News
Research, Studies, Advice
Developed by Yuri Ingultsov Software Lab.